Ola Electric approves allotment of 37,02,72,665 partly paid shares in rights issue
Ola Electric · Automobiles
What the filing says
- Rights issue of 37,02,72,665 partly paid-up equity shares at ₹27 per share incl. ₹17 premium; ₹16.20 paid on application
- Paid-up capital rose from ₹46,28,40,83,130 (4,62,84,08,313 fully paid shares) to ₹48,50,57,19,120 including partly paid shares
- Rights Issue Committee approved the allotment on November 2, 2026; issue offered to eligible shareholders as on record date
Why it's rated notable: Binding rights-issue allotment of 37,02,72,665 partly paid shares at ₹ 27 per share, with no total issue amount stated, so the level stays at medium.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Ola Electric
- Fundraise / allotmentNotableOla Electric Rights Issue of up to ₹1,000 crore closes on October 30, 2026
- Fundraise / allotmentNotableOla Electric board sets terms of partly paid-up rights issue up to ₹1,000 crores
- Fundraise / allotmentNotableOla Electric board approves rights issue of up to ₹1,000 crore at ₹27 per share
- OtherNotableOla Electric Mobility files Letter of Offer for ₹999.74 crore rights issue
- Fundraise / allotmentNotableOla Electric Board approves rights issue of ₹9,99,73,61,955 at ₹27 per share
Other fundraise / allotment filings this fortnight
- Grand Oak Canyons board to consider Rs. 20,67,00,00,000 NCPS allotment on 5 Nov
- Aarti Industries shareholders approve special resolution to raise up to ₹1,000 crore
- Neogen Chemicals reports Q2 FY27 revenues of ₹296 crore, 42% YoY growth
- Evonile Pharma receives BSE in-principle approval for ₹900 crore rights issue
- Evonile Pharma receives BSE approval for ₹90 crore Rights Issue, board meeting set
- Neogen Chemicals Sept-quarter results, ₹600 crore QIP and ₹200 crore NCD redemption plan
Potential multibaggers · Q2 FY27
Potential multibaggers in Automobiles
on management's own guidance
- Strong growth2
- Strong growth1
- M & MGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
